ATE241630T1 - Verfahren zur herstellung von ucn-01 - Google Patents
Verfahren zur herstellung von ucn-01Info
- Publication number
- ATE241630T1 ATE241630T1 AT99125341T AT99125341T ATE241630T1 AT E241630 T1 ATE241630 T1 AT E241630T1 AT 99125341 T AT99125341 T AT 99125341T AT 99125341 T AT99125341 T AT 99125341T AT E241630 T1 ATE241630 T1 AT E241630T1
- Authority
- AT
- Austria
- Prior art keywords
- ucn
- producing
- acidified
- producing ucn
- solution
- Prior art date
Links
- PBCZSGKMGDDXIJ-HQCWYSJUSA-N 7-hydroxystaurosporine Chemical compound N([C@H](O)C1=C2C3=CC=CC=C3N3C2=C24)C(=O)C1=C2C1=CC=CC=C1N4[C@H]1C[C@@H](NC)[C@@H](OC)[C@]3(C)O1 PBCZSGKMGDDXIJ-HQCWYSJUSA-N 0.000 title abstract 7
- PBCZSGKMGDDXIJ-UHFFFAOYSA-N 7beta-hydroxystaurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3C(O)NC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 PBCZSGKMGDDXIJ-UHFFFAOYSA-N 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10364369A JP2000186092A (ja) | 1998-12-22 | 1998-12-22 | Ｕｃｎ−０１の製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE241630T1 true ATE241630T1 (de) | 2003-06-15 |
Family
ID=18481646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99125341T ATE241630T1 (de) | 1998-12-22 | 1999-12-21 | Verfahren zur herstellung von ucn-01 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6197955B1 (enExample) |
| EP (1) | EP1020471B1 (enExample) |
| JP (1) | JP2000186092A (enExample) |
| AT (1) | ATE241630T1 (enExample) |
| CA (1) | CA2293023A1 (enExample) |
| DE (1) | DE69908288T2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887864B2 (en) | 2002-03-12 | 2005-05-03 | Hoffmann-La Roche Inc. | Azepane derivatives |
| EP2256106B1 (en) | 2003-07-22 | 2015-05-06 | Astex Therapeutics Limited | 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators |
| EP1845973B1 (en) * | 2005-01-21 | 2015-08-12 | Astex Therapeutics Limited | Pharmaceutical compounds |
| AR054425A1 (es) | 2005-01-21 | 2007-06-27 | Astex Therapeutics Ltd | Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico. |
| US8404718B2 (en) | 2005-01-21 | 2013-03-26 | Astex Therapeutics Limited | Combinations of pyrazole kinase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62220196A (ja) | 1986-03-20 | 1987-09-28 | Kyowa Hakko Kogyo Co Ltd | 新規物質ｕｃｎ―０１ |
| EP0383919A4 (en) | 1988-02-04 | 1992-08-05 | Kyowa Hakko Kogyo Co., Ltd. | Staurosporin derivatives |
| EP0575955B1 (en) * | 1992-06-22 | 1999-09-15 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing staurosporine derivatives |
-
1998
- 1998-12-22 JP JP10364369A patent/JP2000186092A/ja not_active Abandoned
-
1999
- 1999-12-17 CA CA002293023A patent/CA2293023A1/en not_active Abandoned
- 1999-12-20 US US09/466,903 patent/US6197955B1/en not_active Expired - Fee Related
- 1999-12-21 AT AT99125341T patent/ATE241630T1/de not_active IP Right Cessation
- 1999-12-21 EP EP99125341A patent/EP1020471B1/en not_active Expired - Lifetime
- 1999-12-21 DE DE69908288T patent/DE69908288T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1020471A1 (en) | 2000-07-19 |
| US6197955B1 (en) | 2001-03-06 |
| CA2293023A1 (en) | 2000-06-22 |
| DE69908288D1 (de) | 2003-07-03 |
| EP1020471B1 (en) | 2003-05-28 |
| JP2000186092A (ja) | 2000-07-04 |
| DE69908288T2 (de) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69908998D1 (de) | Verfahren zur Herstellung von Kohlenstoff | |
| DE58908534D1 (de) | Verfahren zur Herstellung von doppelt-haploiden Gurken. | |
| DE69201959D1 (de) | Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol. | |
| DE69101775D1 (de) | Verfahren zur Herstellung von Wasserstoffperoxid. | |
| DE69623550D1 (de) | Verfahren zur Herstellung von Graphitfasern | |
| ATE162551T1 (de) | Verfahren zur herstellung von dihomo-gamma- linolensäure und das in dieser enthaltende lipid | |
| DE68916086D1 (de) | Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen. | |
| DE69521175D1 (de) | Verfahren zur Herstellung von Xanthangummi | |
| DE68909627D1 (de) | Verfahren zur Herstellung von Aktivkohle. | |
| ATE201025T1 (de) | Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren | |
| ATE101144T1 (de) | Verfahren zur herstellung von cyclischen sulfaten. | |
| DE68908576D1 (de) | Verfahren zur Herstellung von Aktivkohle. | |
| DE69903443D1 (de) | Kontinuierliches Verfahren zur Herstellung von optisch reinem (S)-3-Hydroxy-gamma-Butyrolacton | |
| DE69712157D1 (de) | Verfahren zur Herstellung von Acrylnitril | |
| DE68922360D1 (de) | Verfahren zur Herstellung von Metall-Polyimid-Verbundwerkstoffen. | |
| DE69908288D1 (de) | Verfahren zur Herstellung von UCN-01 | |
| DE69620539D1 (de) | Verfahren zur Reinigung von Thrombomodulin | |
| DE69228648D1 (de) | Verfahren zur Herstellung von komplementären, bipolaren Transistoren | |
| DE69519799D1 (de) | Verfahren zur herstellung von [s,s]-ethylendiamin-n,n'-dibernsteinsäure | |
| DE59006645D1 (de) | Verfahren zur kontinuierlichen herstellung von 3,3'-dichlor-benzidin-dihidrochlorid. | |
| ATE262504T1 (de) | Kontinuierliches isothermes verfahren zur herstellung von mononitrotoluolen | |
| DE60106057D1 (de) | Verfahren zur herstellung von baccatin iii-derivativen | |
| ATE174966T1 (de) | Verfahren zur herstellung von biotin | |
| ATE132535T1 (de) | Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg | |
| DE69021001D1 (de) | Enzymatisches Verfahren zur Herstellung von L-Serin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |